GILEAD SCIENCES INC (GIS.DE) Stock Fundamental Analysis

FRA:GIS • US3755581036

131.16 EUR
+2.36 (+1.83%)
Last: Feb 13, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to GIS. GIS was compared to 78 industry peers in the Biotechnology industry. While GIS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. GIS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year GIS was profitable.
  • In the past year GIS had a positive cash flow from operations.
  • Of the past 5 years GIS 4 years were profitable.
  • Of the past 5 years GIS 4 years had a positive operating cash flow.
GIS.DE Yearly Net Income VS EBIT VS OCF VS FCFGIS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1.2 Ratios

  • GIS has a better Return On Assets (13.86%) than 86.42% of its industry peers.
  • With an excellent Return On Equity value of 37.80%, GIS belongs to the best of the industry, outperforming 95.06% of the companies in the same industry.
  • The Return On Invested Capital of GIS (18.54%) is better than 96.30% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for GIS is above the industry average of 11.66%.
  • The last Return On Invested Capital (18.54%) for GIS is above the 3 year average (16.22%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROIC 18.54%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
GIS.DE Yearly ROA, ROE, ROICGIS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

  • GIS's Profit Margin of 27.88% is amongst the best of the industry. GIS outperforms 83.95% of its industry peers.
  • In the last couple of years the Profit Margin of GIS has declined.
  • Looking at the Operating Margin, with a value of 38.96%, GIS belongs to the top of the industry, outperforming 95.06% of the companies in the same industry.
  • In the last couple of years the Operating Margin of GIS has grown nicely.
  • GIS has a better Gross Margin (78.72%) than 65.43% of its industry peers.
  • GIS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
GIS.DE Yearly Profit, Operating, Gross MarginsGIS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • GIS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • There is no outstanding debt for GIS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GIS.DE Yearly Shares OutstandingGIS.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
GIS.DE Yearly Total Debt VS Total AssetsGIS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • GIS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.57
WACC11.8%
GIS.DE Yearly LT Debt VS Equity VS FCFGIS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

  • A Current Ratio of 1.53 indicates that GIS should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.53, GIS is not doing good in the industry: 60.49% of the companies in the same industry are doing better.
  • GIS has a Quick Ratio of 1.17. This is a normal value and indicates that GIS is financially healthy and should not expect problems in meeting its short term obligations.
  • GIS has a worse Quick ratio (1.17) than 62.96% of its industry peers.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.17
GIS.DE Yearly Current Assets VS Current LiabilitesGIS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • GIS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 76.79%, which is quite impressive.
  • GIS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.83% yearly.
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%

3.2 Future

  • Based on estimates for the next years, GIS will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.47% on average per year.
  • GIS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.32% yearly.
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
GIS.DE Yearly Revenue VS EstimatesGIS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B
GIS.DE Yearly EPS VS EstimatesGIS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 19.09 indicates a rather expensive valuation of GIS.
  • GIS's Price/Earnings ratio is rather cheap when compared to the industry. GIS is cheaper than 86.42% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.68, GIS is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 17.44, the valuation of GIS can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of GIS indicates a rather cheap valuation: GIS is cheaper than 88.89% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. GIS is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.09
Fwd PE 17.44
GIS.DE Price Earnings VS Forward Price EarningsGIS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • GIS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GIS is cheaper than 83.95% of the companies in the same industry.
  • 90.12% of the companies in the same industry are more expensive than GIS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 20.28
EV/EBITDA 13.03
GIS.DE Per share dataGIS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GIS does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of GIS may justify a higher PE ratio.
PEG (NY)2.02
PEG (5Y)6.76
EPS Next 2Y8.64%
EPS Next 3Y8.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.16%, GIS has a reasonable but not impressive dividend return.
  • GIS's Dividend Yield is rather good when compared to the industry average which is at 0.50. GIS pays more dividend than 95.06% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.84, GIS has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.16%

5.2 History

  • The dividend of GIS has a limited annual growth rate of 4.45%.
Dividend Growth(5Y)4.45%
Div Incr Years6
Div Non Decr Years6
GIS.DE Yearly Dividends per shareGIS.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 12.00% of the earnings are spent on dividend by GIS. This is a low number and sustainable payout ratio.
  • GIS's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP12%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
GIS.DE Yearly Income VS Free CF VS DividendGIS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
GIS.DE Dividend Payout.GIS.DE Dividend Payout, showing the Payout Ratio.GIS.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

GILEAD SCIENCES INC

FRA:GIS (2/13/2026, 7:00:00 PM)

131.16

+2.36 (+1.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-10
Earnings (Next)04-22
Inst Owners91.58%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap162.73B
Revenue(TTM)N/A
Net Income(TTM)8.11B
Analysts81.62
Price Target120.14 (-8.4%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.16%
Yearly Dividend2.65
Dividend Growth(5Y)4.45%
DP12%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.14%
Min EPS beat(2)0.6%
Max EPS beat(2)13.68%
EPS beat(4)3
Avg EPS beat(4)5.77%
Min EPS beat(4)-0.59%
Max EPS beat(4)13.68%
EPS beat(8)6
Avg EPS beat(8)10.36%
EPS beat(12)8
Avg EPS beat(12)8%
EPS beat(16)11
Avg EPS beat(16)5.39%
Revenue beat(2)1
Avg Revenue beat(2)0.99%
Min Revenue beat(2)-0.31%
Max Revenue beat(2)2.29%
Revenue beat(4)2
Avg Revenue beat(4)0.47%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)3.87%
Revenue beat(8)5
Avg Revenue beat(8)1.32%
Revenue beat(12)8
Avg Revenue beat(12)1.67%
Revenue beat(16)12
Avg Revenue beat(16)2.95%
PT rev (1m)2.9%
PT rev (3m)5.57%
EPS NQ rev (1m)-2.72%
EPS NQ rev (3m)-3.29%
EPS NY rev (1m)-0.48%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)0.64%
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.54%
Valuation
Industry RankSector Rank
PE 19.09
Fwd PE 17.44
P/S 6.64
P/FCF 20.28
P/OCF 19.97
P/B 9
P/tB N/A
EV/EBITDA 13.03
EPS(TTM)6.87
EY5.24%
EPS(NY)7.52
Fwd EY5.73%
FCF(TTM)6.47
FCFY4.93%
OCF(TTM)6.57
OCFY5.01%
SpS19.76
BVpS14.58
TBVpS-3.28
PEG (NY)2.02
PEG (5Y)6.76
Graham Number47.47
Profitability
Industry RankSector Rank
ROA 13.86%
ROE 37.8%
ROCE 24.51%
ROIC 18.54%
ROICexc 23.24%
ROICexgc 80.87%
OM 38.96%
PM (TTM) 27.88%
GM 78.72%
FCFM 32.73%
ROA(3y)5.73%
ROA(5y)5.31%
ROE(3y)16.3%
ROE(5y)15.83%
ROIC(3y)16.22%
ROIC(5y)15.08%
ROICexc(3y)19.38%
ROICexc(5y)17.72%
ROICexgc(3y)93.83%
ROICexgc(5y)93.24%
ROCE(3y)21.45%
ROCE(5y)19.94%
ROICexgc growth 3Y-0.46%
ROICexgc growth 5Y15.06%
ROICexc growth 3Y13.04%
ROICexc growth 5Y6.39%
OM growth 3Y0.61%
OM growth 5Y7.43%
PM growth 3Y-58.16%
PM growth 5Y-41.32%
GM growth 3Y1.06%
GM growth 5Y-0.95%
F-Score7
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 68.56%
Profit Quality 117.39%
Current Ratio 1.53
Quick Ratio 1.17
Altman-Z N/A
F-Score7
WACC11.8%
ROIC/WACC1.57
Cap/Depr(3y)25.08%
Cap/Depr(5y)29.48%
Cap/Sales(3y)2.21%
Cap/Sales(5y)2.28%
Profit Quality(3y)819.86%
Profit Quality(5y)1749.07%
High Growth Momentum
Growth
EPS 1Y (TTM)76.79%
EPS 3Y3.88%
EPS 5Y2.83%
EPS Q2Q%-2.11%
EPS Next Y9.44%
EPS Next 2Y8.64%
EPS Next 3Y8.05%
EPS Next 5Y8.47%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%4.7%
Revenue Next Year3.45%
Revenue Next 2Y4.28%
Revenue Next 3Y4.12%
Revenue Next 5Y4.32%
EBIT growth 1Y4.49%
EBIT growth 3Y2.36%
EBIT growth 5Y12.88%
EBIT Next Year76.07%
EBIT Next 3Y25.58%
EBIT Next 5Y19.26%
FCF growth 1Y21.23%
FCF growth 3Y-1.57%
FCF growth 5Y4.37%
OCF growth 1Y15.03%
OCF growth 3Y-1.66%
OCF growth 5Y3.44%

GILEAD SCIENCES INC / GIS.DE FAQ

What is the fundamental rating for GIS stock?

ChartMill assigns a fundamental rating of 6 / 10 to GIS.DE.


What is the valuation status of GILEAD SCIENCES INC (GIS.DE) stock?

ChartMill assigns a valuation rating of 8 / 10 to GILEAD SCIENCES INC (GIS.DE). This can be considered as Undervalued.


How profitable is GILEAD SCIENCES INC (GIS.DE) stock?

GILEAD SCIENCES INC (GIS.DE) has a profitability rating of 8 / 10.


What is the financial health of GILEAD SCIENCES INC (GIS.DE) stock?

The financial health rating of GILEAD SCIENCES INC (GIS.DE) is 5 / 10.


Can you provide the expected EPS growth for GIS stock?

The Earnings per Share (EPS) of GILEAD SCIENCES INC (GIS.DE) is expected to grow by 9.44% in the next year.